Schedule 13D ownership disclosure

Flex Pharma, Inc.

Security class unavailable · CUSIP: 33938A105

Event date: 2016-05-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
15.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-16-596146
Form type
SC 13D/A
Filer
Salarius Pharmaceuticals, Inc.
CIK
CIK 1615219
Filed
May 19, 2016
Reporting period
May 17, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub